NutriBand (NTRB) Amortizatization of Intangibles (2017 - 2023)
NutriBand (NTRB) posted Amortizatization of Intangibles of $7845.0 for Q3 2023, little changed sequentially from $7845.0 in Q2 2023, and down 47.64% YoY from $14982.0 in Q3 2022.
NutriBand (NTRB) Amortizatization of Intangibles (2017 - 2023) Analysis & Trends
NutriBand has reported Amortizatization of Intangibles for 5 years, with the latest figure at $7845.0 in Q3 2023.
- Quarterly Amortizatization of Intangibles fell 47.64% year-over-year to $7845.0 in Q3 2023, while the trailing twelve-month figure through Jul 2023 was $24536.0 (down 54.84% YoY) and the FY2023 annual result came in at $38813.0, down 60.18% from the prior year.
- Amortizatization of Intangibles was little changed at $7845.0 in Q3 2023 per NTRB's latest filing, from $7845.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $262520.0 in Q1 2021 and troughed at -$3765.0 in Q1 2023.
- A 4-year average of $47092.1 and a median of $14982.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2021 and 2022: Amortizatization of Intangibles soared 660.75% in 2021, then sank 59.01% in 2022.
- Over 4 years, Amortizatization of Intangibles stood at $4805.0 in 2020, then soared by 407.16% to $24369.0 in 2021, then tumbled by 48.25% to $12611.0 in 2022, then slumped by 37.79% to $7845.0 in 2023.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $7845.0, $7845.0, and -$3765.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 7,845.00 |
| Jul 31, 2023 | 7,845.00 |
| Apr 30, 2023 | 7,845.00 |
| Apr 30, 2023 | 7,845.00 |
| Jan 31, 2023 | -3,765.00 |
| Jan 31, 2023 | -3,765.00 |
| Oct 31, 2022 | 12,611.00 |
| Oct 31, 2022 | 12,611.00 |
| Jul 31, 2022 | 14,982.00 |
| Jul 31, 2022 | 14,982.00 |
| Apr 30, 2022 | 14,985.00 |
| Apr 30, 2022 | 14,985.00 |
| Oct 31, 2021 | 24,369.00 |
| Oct 31, 2021 | 24,369.00 |
| Jul 31, 2021 | 36,554.00 |
| Jul 31, 2021 | 36,554.00 |
| Apr 30, 2021 | 36,554.00 |
| Apr 30, 2021 | 36,554.00 |
| Jan 31, 2021 | 262,520.00 |
| Jan 31, 2021 | 262,520.00 |